Company: IPHYF
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001598599-25-000042
Chunk: 342

Company: Innate Pharma SA
Filing Date: 2025-04-30
Form: 20-F
Item: Item 19
Chunk 342
---
)      —                  ( 18)             
  Depreciation                      - 549                                          - 1,027      0                - 1,576             
  Of which right of use assets      ( 420)                                          ( 272)      —                 ( 693)             
  Transfers                         - 159                                              159      0                      0             
  Of which right of use assets      —                                                    —      —                      —             
  Foreign exchange variation        14                                                   1      0                     15             
  Of which right of use assets      14                                                   —      —                     14             
  December 31, 2024                                                                  2,285      2,861 —                       5,133  
  Of which right of use assets      1,269                                            1,121      —                  2,390             

F-41

8)Trade payables and others

This line item is analyzed as follows:

                                                                                    December 31,                                      
  (in thousands of euro)                                                                    2022                                      
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Suppliers (excluding payables related to capital expenditures)                                      13,656       8,561       7,923  
  Tax and employee-related payables                                                                    5,978       7,021       6,962  
  Other payables (1)                                                                                   1,260       1,436       1,122  
  Trade payables and others excluding payables related to capital expenditures                        20,894      17,018      16,007  
  Payables related to capital expenditures                                                    17                                      
  Payables and others                                                                                 20,911      17,018      16,007  

(1) As of December 31, 2022, 2023 and 2024, this amount mainly includes the liability relating to the payment of the guarantee fees on thetwoState Guaranteed Loans obtained from Société Générale and BNP Paribas in 2021. The cost of the guarantee is spread out until the end of the repayment of said loans, i. e., December 31, 2027 (see note 9).

The book value of trade payables and others is considered to be a reasonable approximation of their fair value.

9)Financial liabilities

This line item was broken down per maturity and is analyzed as follows:

  In thousand euros